title: Microsporum canis antifungal susceptibilities: concerns regarding their clinical predictability.
authors.forename: Michael
authors.initials: M
authors.lastname: Arabatzis
authors.forename: Miltiades
authors.initials: M
authors.lastname: Kyprianou
authors.forename: Aristea
authors.initials: A
authors.lastname: Velegraki
authors.forename: Antonia
authors.initials: A
authors.lastname: Makri
authors.forename: Aliki
authors.initials: A
authors.lastname: Voyatzi
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D002415:Cats; D002648:Child; D002675:Child, Preschool; D006115:Greece; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards; D008864:Microsporum / Q000187:drug effects*; D011237:Predictive Value of Tests; D014005:Tinea / Q000188:drug therapy* / Q000469:parasitology; D014006:Tinea Capitis / Q000188:drug therapy* / Q000469:parasitology; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents